1. Home
  2. STIM vs ICG Comparison

STIM vs ICG Comparison

Compare STIM & ICG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$2.09

Market Cap

105.5M

Sector

Health Care

ML Signal

HOLD

Logo Intchains Group Limited

ICG

Intchains Group Limited

N/A

Current Price

$1.77

Market Cap

97.1M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
STIM
ICG
Founded
2003
2017
Country
United States
China
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
105.5M
97.1M
IPO Year
2018
2023

Fundamental Metrics

Financial Performance
Metric
STIM
ICG
Price
$2.09
$1.77
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$7.00
$7.50
AVG Volume (30 Days)
1.4M
88.5K
Earning Date
11-04-2025
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
94.43
EPS
N/A
0.21
Revenue
$129,873,000.00
$36,367,850.00
Revenue This Year
$101.67
N/A
Revenue Next Year
$10.87
$75.98
P/E Ratio
N/A
$8.40
Revenue Growth
78.61
6.53
52 Week Low
$1.25
$0.93
52 Week High
$5.92
$4.66

Technical Indicators

Market Signals
Indicator
STIM
ICG
Relative Strength Index (RSI) 68.69 52.77
Support Level $1.34 $1.75
Resistance Level $1.50 $1.86
Average True Range (ATR) 0.16 0.16
MACD 0.09 -0.02
Stochastic Oscillator 94.80 35.42

Price Performance

Historical Comparison
STIM
ICG

About STIM Neuronetics Inc.

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

About ICG Intchains Group Limited

Intchains Group Ltd provides integrated solutions consisting of high-performance ASIC chips and ancillary software and hardware for blockchain applications. Its ASIC chips are designed for several key blockchain algorithms including Blake2bsha3, sha512MD160, Cryptonight V4, Eaglesong, Blake2s and others. The company has built a proprietary technology platform named Xihe Platform, which allows the development of a wide range of ASIC chips with high efficiency and scalability. It designs its ASIC chips in-house, which enables it to leverage proprietary silicon data to deliver products reflecting the latest technological developments. Geographically, it operates in Mainland China, Hong Kong, and Other countries or regions.

Share on Social Networks: